IL6 and Peri-Implantitis: Our findings showed that both peri-implantitis groups exhibited greater IL6 production, compared with normal healthy group, while mangiferin-treated peri-implantitis group had less IL6 production, compared with vehicle-treated peri-implantitis group, implying that the therapeutic effect of mangiferin may be associated with reduced IL6 levels.